Varun Vijay Kumar Monga MD

Oncology•Iowa City, IA

Fellow Physician Hematology/Oncology

Join to View Full Profile

200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-4422

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2013 - 2016
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2007 - 2011
Rajiv Gandhi Medical CollegeClass of 2005
University of Iowa Hospitals and ClinicsResidency, Internal Medicine

Certifications & Licensure

CA State Medical License 2023 - 2027
IA State Medical License 2011 - 2023
AZ State Medical License 2015 - 2019
IL State Medical License 2007 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Gemcitabine Plus Ascorbate for Sarcoma in Adults Start of enrollment: 2018 Jul 11
Terminated
Phase 2
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas Start of enrollment: 2019 Jun 27
COMPLETED
PHASE1, PHASE2
Anti-Osteoclast Therapy As Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial Start of enrollment: 2017 Jul 18
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Sponsor-Investigator, Principal Investigator, Contact
Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma Start of enrollment: 2023 Apr 01
Withdrawn
Not Applicable
Roles: Sponsor-Investigator, Contact, Principal Investigator
TVEC and Preop Radiation for Sarcoma (8 ml Dose) Start of enrollment: 2020 Sep 10
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact, Principal Investigator, Sponsor-Investigator
PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Start of enrollment: 2015 Nov 04
TERMINATED
PHASE1, PHASE2
Roles: Principal Investigator, Contact
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration Start of enrollment: 2019 Oct 07
Recruiting
Phase 2
Roles: Contact
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations Start of enrollment: 2021 Feb 28
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Principal Investigator, Contact
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations Start of enrollment: 2021 Feb 28
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Chlorpromazine and Standard of Care in Glioblastoma Start of enrollment: 2022 Jan 28
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Contact, Principal Investigator, Sponsor-Investigator
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) Start of enrollment: 2020 Nov 24
ACTIVE_NOT_RECRUITING
EARLY_PHASE1
Roles: Sponsor-Investigator, Contact, Principal Investigator
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 2020 Jan 14
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

12 citations
A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression
Sriram Ramaswamy, David Driscoll, Christopher Reist, Lynette M. Smith, Lawrence J. Albers
The Primary Care Companion for CNS Disorders. 2017-08-24
87 citations
Erratum: O2 ⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate (Cancer ...
Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar, Brett A. Wagner, Kimberly L. Cramer-Morales
Cancer Cell. 2017-08-14
2 citations
Rapid Correction of Chronic Hyponatremia Secondary to Psychogenic Polydipsia: Hypoxic Injury or Extrapontine Myelinolysis?
Kellie Lynn Nelson, Varun Monga, Ashish Sharma, Thomas Blount
The Primary Care Companion for CNS Disorders. 2016-10-20

Press Mentions

UI Researchers Investigating Photosensitizing Drug to Treat Soft Tissue SarcomasApril 28th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member